Lipid metabolic reprogramming in cancer cells - Archive ouverte HAL Access content directly
Journal Articles Oncogenesis Year : 2016

Lipid metabolic reprogramming in cancer cells


Many human diseases, including metabolic, immune and central nervous system disorders, as well as cancer, are the consequence of an alteration in lipid metabolic enzymes and their pathways. This illustrates the fundamental role played by lipids in maintaining membrane homeostasis and normal function in healthy cells. We reviewed the major lipid dysfunctions occurring during tumor development, as determined using systems biology approaches. In it, we provide detailed insight into the essential roles exerted by specific lipids in mediating intracellular oncogenic signaling, endoplasmic reticulum stress and bidirectional crosstalk between cells of the tumor microenvironment and cancer cells. Finally, we summarize the advances in ongoing research aimed at exploiting the dependency of cancer cells on lipids to abolish tumor progression.
Fichier principal
Vignette du fichier
Oncogenesis 2016.pdf (1.64 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03962132 , version 1 (30-01-2023)


Attribution - CC BY 4.0



S Beloribi-Djefaflia, S Vasseur, F Guillaumond. Lipid metabolic reprogramming in cancer cells. Oncogenesis, 2016, 5, pp.e189 - e189. ⟨10.1038/oncsis.2015.49⟩. ⟨hal-03962132⟩


22 View
3 Download



Gmail Facebook Twitter LinkedIn More